Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis.
Ovidio De FilippoGianluca Di PietroMarco NebioloDavide Giuseppe RibaldoneMarco GattiFrancesco BrunoGuglielmo GalloneAngelo ArmandiLucia Ilaria BirtoloVeronica ZullinoGianluca MenniniStefano Ginanni CorradiniMassimo ManconeElisabetta BugianesiMario IannacconeGaetano Maria De FerrariFabrizio D'AscenzoPublished in: European journal of clinical investigation (2024)
Patients with MASLD are at increased risk of developing critical coronary stenosis and coronary plaques characterized by high-risk features as detected by CTCA.